| P50 | author | Henry Seth Friedman | Q73422966 |
| | Annick Desjardins | Q73536038 |
| | Katherine B Peters | Q89702623 |
| | Frances McSherry | Q104937686 |
| | James H. Herndon | Q112381232 |
| | Whitney E Hornsby | Q116793248 |
| | Emily Waner | Q116793249 |
| | April Coan | Q40577753 |
| P2093 | author name string | Lee W Jones | |
| | Miranda J West | |
| P2860 | cites work | Methylphenidate therapy improves cognition, mood, and function of brain tumor patients | Q48429646 |
| | Compromised health-related quality of life in patients with low-grade glioma | Q48566104 |
| | Prospective study of quality of life in adults with newly diagnosed high-grade gliomas. | Q48767866 |
| | A prospective study of quality of life in adults with newly diagnosed high-grade gliomas: the impact of the extent of resection on quality of life and survival. | Q48786139 |
| | Comparison of proposed diagnostic criteria with FACT-F and VAS for cancer-related fatigue: proposal for use as a screening tool | Q49128726 |
| | A phase III, double-blind, placebo-controlled prospective randomized clinical trial of d-threo-methylphenidate HCl in brain tumor patients receiving radiation therapy. | Q51899324 |
| | Psychological distress and fatigue predicted recurrence and survival in primary breast cancer patients. | Q51908268 |
| | Impact of cancer-related fatigue on the lives of patients: new findings from the Fatigue Coalition. | Q51972915 |
| | Fatigue in cancer patients compared with fatigue in the general United States population. | Q52545589 |
| | The Functional Assessment of Cancer Therapy (FACT) scale. Development of a brain subscale and revalidation of the general version (FACT-G) in patients with primary brain tumors. | Q52880557 |
| | Cognitive function as a predictor of survival in patients with recurrent malignant glioma. | Q53531491 |
| | Epidemiology of brain tumors. | Q55465493 |
| | Medical management of patients with brain tumors | Q84071260 |
| | Cancer-Related Fatigue: Definitions and Clinical Subtypes | Q85093460 |
| | Quality of life data as prognostic indicators of survival in cancer patients: an overview of the literature from 1982 to 2008. | Q22241762 |
| | Long-term effects of radiation therapy on cognitive and endocrine function in children with leukemia and brain tumors | Q28290890 |
| | The prognostic value of health-related quality-of-life data in predicting survival in glioblastoma cancer patients: results from an international randomised phase III EORTC Brain Tumour and Radiation Oncology Groups, and NCIC Clinical Trials Group s | Q31117641 |
| | Medical management of brain tumor patients | Q31134402 |
| | Prognostic value of health-related quality-of-life data in predicting survival in patients with anaplastic oligodendrogliomas, from a phase III EORTC brain cancer group study | Q33311103 |
| | Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials | Q33495456 |
| | Progress toward guidelines for the management of fatigue. | Q33535544 |
| | Health-related quality of life in glioma patients in China | Q33611220 |
| | NCCN Practice Guidelines for Cancer-Related Fatigue | Q33934297 |
| | Cancer-related fatigue and its associations with depression and anxiety: a systematic review | Q33985669 |
| | NCCN Clinical Practice Guidelines Cancer-related fatigue | Q34140074 |
| | Factors influencing quality of life in cancer patients: anemia and fatigue. | Q34749557 |
| | Impact of brain tumour treatment on quality of life | Q34796299 |
| | Exercise behavior, functional capacity, and survival in adults with malignant recurrent glioma | Q35112333 |
| | Facets and determinants of quality of life in patients with recurrent high grade glioma | Q35486970 |
| | Effect of exercise training on peak oxygen consumption in patients with cancer: a meta-analysis. | Q35584318 |
| | Fatigue and endocrine disorders. Causes and comorbidities. | Q35598206 |
| | Fatigue and cancer: causes, prevalence and treatment approaches | Q35828557 |
| | Role and relevance of neurocognitive assessment in clinical trials of patients with CNS tumors | Q36416761 |
| | Multiple significance tests: the Bonferroni method | Q36901984 |
| | Fatigue is the most important symptom for advanced cancer patients who have had chemotherapy | Q37385178 |
| | Treatment of recurrent high-grade gliomas | Q37601217 |
| | Review on quality of life issues in patients with primary brain tumors | Q37761238 |
| | An algorithm for chemotherapy treatment of recurrent glioma patients after temozolomide failure in the general oncology setting | Q37858468 |
| | A randomized trial on the efficacy of methylphenidate and modafinil for improving cognitive functioning and symptoms in patients with a primary brain tumor | Q39701844 |
| | Risk factors for fatigue severity in primary brain tumor patients. | Q39891162 |
| | Quality of life as a potential predictor for morbidity and mortality in patients with metastatic hormone-refractory prostate cancer | Q40308580 |
| | Outcomes and prognostic factors in recurrent glioma patients enrolled onto phase II clinical trials | Q40789890 |
| | The correlation between fatigue, physical function, the systemic inflammatory response, and psychological distress in patients with advanced lung cancer | Q44126920 |
| | Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group | Q48271471 |
| | Hypothalamic-pituitary dysfunction after radiation for brain tumors | Q48346818 |
| P433 | issue | 3 | |
| P304 | page(s) | 499-506 | |
| P577 | publication date | 2014-08-13 | |
| P1433 | published in | Journal of Neuro-Oncology | Q15752119 |
| P1476 | title | Impact of health-related quality of life and fatigue on survival of recurrent high-grade glioma patients | |
| P478 | volume | 120 | |